In recent years, psilocybin has been increasingly used in research studies. It has achieved impressively high success rates for issues such as non-treatable depression, end of life anxiety, PTSD, smoking addiction, and a host of other disorders that are difficult to cure. That research has led to a revival of interest in some of the compounds that President Nixon blacklisted in 1971. He then classified them as Schedule 1 controlled substances as they...